A carregar...
Late relapses in primary CNS lymphoma after complete remissions with high-dose methotrexate monotherapy
Treatment of patients with newly diagnosed primary CNS lymphomas using high dose methotrexate regimens is reported to yield about 30% long term survivors with minimal neurotoxicity. As in other systemic large cell lymphomas, it is generally assumed that most relapses occur within 5 years of diagnosi...
Na minha lista:
| Publicado no: | CNS Oncol |
|---|---|
| Main Authors: | , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Future Medicine Ltd
2015
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4834699/ https://ncbi.nlm.nih.gov/pubmed/26507609 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2217/cns.15.34 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|